Bioline Rx reported $280K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 4.6M 4.1M Mar/2026
Bio Path 677K 547K Mar/2026
Bioline Rx USD 280K 80K Dec/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025